Navigation Links
RxISK Seeks Reports from AbbVie Customers as part of campaign launched today by Dr. David Healy
Date:7/15/2013

Toronto, Canada (PRWEB) July 15, 2013

RxISK.org, the first free independent website for researching and reporting prescription drug side effects, is helping a campaign to capture patient reported side effects of a range of drugs sold by the pharmaceutical company AbbVie - the recent spun-off entity of Abbott Laboratories.

The campaign was announced by Dr. David Healy, a leading drug safety advocate and psychopharmacologist, in his recent blog post on DavidHealy.org.

As reported in the PharmaTimes May 1, 2013, AbbVie and InterMune sued the European Medicines Agency (EMA) to prevent the release of data and obtained an interim injunction to prevent the release. Bloomberg reports July 12, 2013, that this interim decision is being appealed by EMA.

(Interim decision see C-389/13 P, EMA v. AbbVie, C-390/13 P, EMA v. InterMune U.K. and Others.)

"Since most drugs are marketed and used globally this data could have global significance," says Dr. Healy. Healy is among the growing group of high profile advocates for access to complete data.

Dr. Healy says, “data transparency would be an important first step in helping patients and their doctors make informed decisions on the benefits and risks of prescription medicines by enabling independent validation. We urge everyone to make their voices heard on this issue”.

“Side effects know no borders and in this campaign we want to use RxISK.org to collect patient reports about their experiences on AbbVie drugs from every corner of the planet. We will share these results with everyone – including AbbVie,” says Healy.

AbbVie drugs include:
Humira
Depakote
Kaletra (for HIV/AIDs)
Androgrel (for low Testosterone)
Lupron used (for prostate cancer, breast cancer and endometriosis)
Esbriet

RxISK — your megaphone to help change drug safety
RxISK.org allows users to enter the name of a prescription drug and see the side effects that have been reported to the FDA since 2004, as well as to RxISK, for more than 35,000 drug names from 103 countries. The data is presented in tables, tag clouds, heat maps, and interactive graphs, showing what’s happening with other people taking the same drug around the world.

Users can then select the effect(s) they are experiencing and click on Report a Drug Side Effect to complete a report. They get a personalized RxISK Report linking their symptoms and meds, which they can take to their doctor or pharmacist to facilitate a better treatment conversation. This will also add their anonymized experience to the RxISK database so that others can benefit from this information.

About Data Based Medicine Americas Ltd.
RxISk.org is owned and operated by Data Based Medicine Americas Ltd. (DBM), based in Toronto, Canada. DBM's founders have international reputations in early drug-side-effect detection and risk mitigation, pharmacovigilance, and patient-centered care. Although drug side effects are known to be a leading cause of death and disability, less than 5% of serious drug side effects are reported. DBM’s mission is to capture this missing data directly from patients through RxISK.org’s free drug side effect reporting tool and use this data to help make medicines safer for all of us.

Media contact
David Carmichael
david(dot)carmichael(at)RxISK(dot)org
+1 (647) 799-3792

Read the full story at http://www.prweb.com/releases/2013/7/prweb10927778.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. RxISK.org’s Dr. Healy Coming to Talk to U.S. Audiences About Deadly Prescription Drug Side Effects
2. Special Needs Organization Seeks Parents In Need of a Mentor
3. RundleFit Seeks Promotional Partnership with Socially Responsible, Healthy Lifestyle Brands For Their Six-Week Jump Start/Positive Incentive Program
4. Milaa Event Seeks to Improve a Child’s Academic Learning Through Outdoor Play
5. WEDI Selects Co-Chairs and Seeks Participants for New 2013 WEDI Report Workgroups
6. Announcement: American Garment Manufacturer, Nouvelle, Inc., Seeks Medical and Plastic Surgery Supply Vendors to Distribute USA-Made Compression Wear
7. Bergener & Associates: Woman Who Almost Died After Contracting Hantavirus in June 2012 Seeks Compensation
8. Life Extension Foundation Seeks Volunteers with Alzheimer's to Participate in a Clinical Trial Utilizing a Common Arthritis Drug
9. d’Oliveira & Associates Seeks Clients That Have Been Affected by the Prescription Drug Topamax
10. Eczema Nonprofit Seeks to Shine New Light on Overlooked Condition
11. hCGTreatments / Diet Doc hCG Diet and Weight Loss Plans Seeks Intellectual Property Protection for Their Prescription hCG Diets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF Orthopaedic Center ... Houston Area. The new location is located at 2255 E. Mossy Oaks Rd., Suite ... This newest location will provide patients living in the north Houston area (The Woodlands, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy ... 960 Gruene Road in Building 2. The clinic is the group’s second in New ... says opening the company’s second New Braunfels location brings things full circle for the ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The IoT ... and WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... estimates the IoT will have a value anywhere from $4 trillion to $11 trillion ...
(Date:3/23/2017)... ... ... of adults are unaware of the dangers that infectious bacteria play in mouth disease, while ... a day that dentists recommend. The ramifications of improper oral upkeep go far beyond bad ... 164 million hours of work each year due to dental issues. That is why Mediaplanet ...
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and ... health. Every day, two kidneys filter about 120 to 150 quarts of blood. Put ... waste, regulating fluid levels and blood pressure, supporting bone health and promoting red blood ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the ... Strategies" report to their offering. ... Pain Management in the ... their physical pain, emphasizing consumer survey analysis, including trends over ... adults who have selected illnesses/conditions strongly associated with physical pain ...
(Date:3/24/2017)... 24, 2017 ShangPharma, a leading ... cost-effective drug development and discovery services, technology, ... industry, announced today the intent for a ... be consolidating the Contract Research Organizations (CRO) ... ChemPartner. These entities include ChemPartner Shanghai, ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: